VDR and melanoma: However, it was also shown that the antiproliferative activity of short side-chain analogs of vitamin D3, such as 21(OH)pD, were not fully dependent on VDR expression in rodent melanomas [56], consistent with the poor docking score on the ligand binding domain of the VDR and the poor translocation of VDR to the nucleus [69].